Ask AI
Public Law114th CongressCrime and Law Enforcement
S. 32Became Law

Transnational Drug Trafficking Act of 2015

This bill became law

Filed
Comm.
Floor
Both
Law

What it doesSummary public law (May 16, 2016)

(This measure has not been amended since it was introduced. The expanded summary of the Senate reported version is repeated here.)

Transnational Drug Trafficking Act of 2015

(Sec. 2) This bill amends the Controlled Substances Import and Export Act to broaden the scope of persons subject to criminal prosecution for manufacturing or distributing a controlled substance in schedule I or II, a precursor chemical, or flunitrazepam for unlawful import into the United States. The Controlled Substances Act classifies drugs, substances, and chemicals used to make drugs into one of five schedules based on the drug's medical use, potential for abuse, and risk of dependence.

Current law prohibits such manufacture or distribution by a person who knows or intends that the substance or chemical will be unlawfully imported. This bill broadens the scope to also prohibit such manufacture or distribution by a person who reasonably believes that the substance or chemical will be unlawfully imported.

In addition, this bill prohibits the manufacture or distribution of a precursor chemical by a person who: (1) knows or intends that the chemical will be used to manufacture a controlled substance; and (2) knows, intends, or reasonably believes that the controlled substance will be unlawfully imported into the United States.

(Sec. 3) The legislation amends the federal criminal code to replace statutory references to prohibited trafficking in a "counterfeit drug" with references to prohibited trafficking in a "drug that uses a counterfeit mark on or in connection with the drug."

What just happenedMay 16, 2016

Became Public Law No: 114-154.

Who’s behind it

Sen. Feinstein, Dianne [D-CA](D-CA)Sponsor
9 cosponsors6 D3 R
Read on Congress.gov
9cosponsors5committees31actions2related bills3subjects
  • Enrolled Bill
  • Referred in HouseOct 8, 2015
  • Engrossed in SenateOct 7, 2015
  • Reported to SenateSep 17, 2015
  • Committee Discharged SenateJan 13, 2015
  • Introduced in SenateJan 6, 2015
  • Public LawMay 17, 2016
  1. May 16, 2016President

    Became Public Law No: 114-154.

  2. May 16, 2016BecameLaw36000

    Became Public Law No: 114-154.

  3. May 16, 2016President

    Signed by President.

  4. May 16, 2016BecameLaw36000

    Signed by President.

  5. May 13, 2016Floor

    Presented to President.

  6. May 13, 2016President28000

    Presented to President.

  7. May 10, 2016FloorH38310

    Motion to reconsider laid on the table Agreed to without objection.

  8. May 10, 2016FloorH37300

    On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2175)

  9. May 10, 2016Floor8000

    Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H2175)

  10. May 10, 2016FloorH8D000

    DEBATE - The House proceeded with forty minutes of debate on S. 32.

  11. May 10, 2016FloorH30000

    Considered under suspension of the rules. (consideration: CR H2175-2179)

  12. May 10, 2016FloorH30300

    Mr. Goodlatte moved to suspend the rules and pass the bill.

  13. Nov 17, 2015Committee

    Committee on United States Senate Caucus on International Narcotics Control. Hearings held.

  14. Nov 3, 2015Committee

    Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

  15. Oct 9, 2015Committee

    Referred to the Subcommittee on Health.

  16. Oct 8, 2015IntroReferralH11100

    Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  17. Oct 8, 2015IntroReferralH11100-A

    Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  18. Oct 8, 2015IntroReferralH11100

    Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  19. Oct 8, 2015Floor

    Message on Senate action sent to the House.

  20. Oct 8, 2015FloorH14000

    Received in the House.

  21. Oct 7, 2015Floor

    Passed Senate without amendment by Unanimous Consent. (consideration: CR S7223; text as passed Senate: CR S7223)

  22. Oct 7, 2015Floor17000

    Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR S7223; text as passed Senate: CR S7223)

  23. Sep 17, 2015Calendars

    Placed on Senate Legislative Calendar under General Orders. Calendar No. 232.

  24. Sep 17, 2015Committee

    Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.

  25. Sep 17, 2015Committee14000

    Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.

  26. Sep 17, 2015Committee

    Committee on the Judiciary. Ordered to be reported without amendment favorably.

  27. Jan 13, 2015IntroReferral

    Referred to the Committee on the Judiciary by unanimous consent.

  28. Jan 13, 2015Discharge

    Senate Committee on Finance discharged by Unanimous Consent.

  29. Jan 13, 2015Committee14500

    Senate Committee on Finance discharged by Unanimous Consent.

  30. Jan 6, 2015IntroReferral

    Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S18-19)

  31. Jan 6, 2015IntroReferral10000

    Introduced in Senate

Public LawMay 16, 201649

(This measure has not been amended since it was introduced. The expanded summary of the Senate reported version is repeated here.)

Transnational Drug Trafficking Act of 2015

(Sec. 2) This bill amends the Controlled Substances Import and Export Act to broaden the scope of persons subject to criminal prosecution for manufacturing or distributing a controlled substance in schedule I or II, a precursor chemical, or flunitrazepam for unlawful import into the United States. The Controlled Substances Act classifies drugs, substances, and chemicals used to make drugs into one of five schedules based on the drug's medical use, potential for abuse, and risk of dependence.

Current law prohibits such manufacture or distribution by a person who knows or intends that the substance or chemical will be unlawfully imported. This bill broadens the scope to also prohibit such manufacture or distribution by a person who reasonably believes that the substance or chemical will be unlawfully imported.

In addition, this bill prohibits the manufacture or distribution of a precursor chemical by a person who: (1) knows or intends that the chemical will be used to manufacture a controlled substance; and (2) knows, intends, or reasonably believes that the controlled substance will be unlawfully imported into the United States.

(Sec. 3) The legislation amends the federal criminal code to replace statutory references to prohibited trafficking in a "counterfeit drug" with references to prohibited trafficking in a "drug that uses a counterfeit mark on or in connection with the drug."

Passed House without amendmentMay 10, 201681

(This measure has not been amended since it was introduced. The expanded summary of the Senate reported version is repeated here.)

Transnational Drug Trafficking Act of 2015

(Sec. 2) This bill amends the Controlled Substances Import and Export Act to broaden the scope of persons subject to criminal prosecution for manufacturing or distributing a controlled substance in schedule I or II, a precursor chemical, or flunitrazepam for unlawful import into the United States. The Controlled Substances Act classifies drugs, substances, and chemicals used to make drugs into one of five schedules based on the drug's medical use, potential for abuse, and risk of dependence.

Current law prohibits such manufacture or distribution by a person who knows or intends that the substance or chemical will be unlawfully imported. This bill broadens the scope to also prohibit such manufacture or distribution by a person who reasonably believes that the substance or chemical will be unlawfully imported.

In addition, this bill prohibits the manufacture or distribution of a precursor chemical by a person who: (1) knows or intends that the chemical will be used to manufacture a controlled substance; and (2) knows, intends, or reasonably believes that the controlled substance will be unlawfully imported into the United States.

(Sec. 3) The legislation amends the federal criminal code to replace statutory references to prohibited trafficking in a "counterfeit drug" with references to prohibited trafficking in a "drug that uses a counterfeit mark on or in connection with the drug."

Passed Senate without amendmentOct 7, 201582

(This measure has not been amended since it was introduced. The expanded summary of the Senate reported version is repeated here.)

Transnational Drug Trafficking Act of 2015

(Sec. 2) This bill amends the Controlled Substances Import and Export Act to broaden the scope of persons subject to criminal prosecution for manufacturing or distributing a controlled substance in schedule I or II, a precursor chemical, or flunitrazepam for unlawful import into the United States. The Controlled Substances Act classifies drugs, substances, and chemicals used to make drugs into one of five schedules based on the drug's medical use, potential for abuse, and risk of dependence.

Current law prohibits such manufacture or distribution by a person who knows or intends that the substance or chemical will be unlawfully imported. This bill broadens the scope to also prohibit such manufacture or distribution by a person who reasonably believes that the substance or chemical will be unlawfully imported.

In addition, this bill prohibits the manufacture or distribution of a precursor chemical by a person who: (1) knows or intends that the chemical will be used to manufacture a controlled substance; and (2) knows, intends, or reasonably believes that the controlled substance will be unlawfully imported into the United States.

(Sec. 3) The legislation amends the federal criminal code to replace statutory references to prohibited trafficking in a "counterfeit drug" with references to prohibited trafficking in a "drug that uses a counterfeit mark on or in connection with the drug."

Reported to Senate without amendmentSep 17, 201580

(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)

Transnational Drug Trafficking Act of 2015

(Sec. 2) This bill amends the Controlled Substances Import and Export Act to broaden the scope of persons subject to criminal prosecution for manufacturing or distributing a controlled substance in schedule I or II, a precursor chemical, or flunitrazepam for unlawful import into the United States. The Controlled Substances Act classifies drugs, substances, and chemicals used to make drugs into one of five schedules based on the drug's medical use, potential for abuse, and risk of dependence.

Current law prohibits such manufacture or distribution by a person who knows or intends that the substance or chemical will be unlawfully imported. This bill broadens the scope to also prohibit such manufacture or distribution by a person who reasonably believes that the substance or chemical will be unlawfully imported.

In addition, this bill prohibits the manufacture or distribution of a precursor chemical by a person who: (1) knows or intends that the chemical will be used to manufacture a controlled substance; and (2) knows, intends, or reasonably believes that the controlled substance will be unlawfully imported into the United States.

(Sec. 3) The legislation amends the federal criminal code to replace statutory references to prohibited trafficking in a "counterfeit drug" with references to prohibited trafficking in a "drug that uses a counterfeit mark on or in connection with the drug."

Introduced in SenateJan 6, 2015

Transnational Drug Trafficking Act of 2015

Amends the Controlled Substances Import and Export Act to prohibit the manufacture or distribution of a controlled substance in schedule I or II, flunitrazepam, or a listed chemical by individuals having reasonable cause to believe that such substance or chemical will be unlawfully imported into the United States or into waters within 12 miles of the U.S. coast.

Prohibits the manufacture or distribution of a listed chemical: (1) intending or knowing that it will be used to manufacture a controlled substance; and (2) intending, knowing, or having reasonable cause to believe that the substance will be unlawfully imported into the United States.

Amends the federal criminal code to revise the prohibition against, and penalties for, intentionally trafficking in a counterfeit drug to apply to intentionally trafficking in a drug and knowingly using a counterfeit mark on or in connection with such drug.

Transnational Drug Trafficking Act of 2015 — Informed